Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Copaxone
Active Ingredient: Glatiramer acetate 20mg
Dosage Form: Powder for injection
New Zealand Sponsor: Aventis Pharma Limited
Manufacturer: Teva Pharmaceutical Industries Limited, Ikapharm, Kfar Saba, Israel
Note: This consent is valid for two years from 24 May 2003.
Dated this 12th day of March 2003.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).